Accretion Nutrav

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1KVQ01019
  • NSEID:
  • BSEID: 544694
INR
283.00
11.3 (4.16%)
BSENSE

May 08

BSE+NSE Vol: 10000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

10.0 k (-26.47%) Volume

Shareholding (Feb 2026)

FII

6.04%

Held by 1 FIIs

DII

6.51%

Held by 0 DIIs

Promoter

73.48%

When is the next results date for Accretion Nutraveda Ltd?

05-May-2026

The next results date for Accretion Nutraveda Ltd is 08 May 2026.

The next results date for Accretion Nutraveda Ltd is scheduled for 08 May 2026.

View full answer

Why is Accretion Nutraveda Ltd falling/rising?

09-May-2026

As of 08-May, Accretion Nutraveda Ltd's stock price is rising, currently at Rs. 283.00, reflecting a 4.16% increase. The stock has shown strong performance with a 38.62% rise over the last month and is trading above key moving averages, indicating a bullish trend and strong investor interest.

As of 08-May, Accretion Nutraveda Ltd's stock price is rising, currently at Rs. 283.00, reflecting an increase of Rs. 11.3 or 4.16%. The stock has shown strong performance over the past week, gaining 5.79%, and has significantly outperformed the benchmark Sensex, which only increased by 0.54% during the same period. <BR><BR>In the last month, the stock has surged by 38.62%, while the Sensex has declined by 0.30%. This upward trend is further supported by the stock hitting a new 52-week and all-time high of Rs. 300 today, indicating strong investor interest and confidence. The stock has also been on a consecutive gain streak for the last three days, accumulating a total return of 11.64% in this timeframe.<BR><BR>Today's trading session began positively, with the stock opening with a gap up of 10.42%. Additionally, Accretion Nutraveda Ltd is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a bullish trend. The rising investor participation is evident, with a delivery volume increase of 7.84% compared to the 5-day average, indicating that more investors are willing to hold the stock rather than trade it immediately.<BR><BR>Overall, the combination of strong recent performance, positive trading momentum, and increased investor participation contributes to the rising stock price of Accretion Nutraveda Ltd.

View full answer

Which are the latest news on Accretion Nutrav?

09-May-2026

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 197 Cr (Micro Cap)

stock-summary
P/E

78.00

stock-summary
Industry P/E

35

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
60.16%
0%
60.16%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Accretion Nutrav for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Board Meeting Intimation for Board Meeting Intimation For Consider And Approve Audited Financial Results For The Year Ended On 31St March 2026

01-May-2026 | Source : BSE

Accretion Nutraveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 inter alia to consider and approve Audited Financial Result for the Year Ended on 31st March 2026

Clarification On Price Movement

30-Apr-2026 | Source : BSE

Please find enclosed herewith clarification Letter on price movement

Clarification sought from Accretion Nutraveda Ltd

29-Apr-2026 | Source : BSE

The Exchange has sought clarification from Accretion Nutraveda Ltd on April 29 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.

The reply is awaited.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
2.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
17.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.54%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
78
Industry P/E
35
Price to Book Value
NA
EV to EBIT
58.88
EV to EBITDA
55.08
EV to Capital Employed
NA
EV to Sales
12.81
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
NA
ROE (Latest)
NA

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
Bullish
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Feb 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (6.04%)

Promoter with highest holding

Ankurkumar Shantilal Patel (14.7%)

Highest Public shareholder

Unicorn Fund (6.51%)

Individual Investors Holdings

10.48%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Accretion Nutrav"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 38.98% vs 29.59% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is 15.45% vs 35.47% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.54",
          "val2": "14.06",
          "chgp": "38.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.56",
          "val2": "3.29",
          "chgp": "8.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.27",
          "val2": "0.26",
          "chgp": "3.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.69",
          "val2": "2.33",
          "chgp": "15.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.22%",
          "val2": "23.40%",
          "chgp": "-5.18%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Accretion Nutrav"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 110.00% vs 219.36% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 102.80% vs 204.88% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "33.60",
          "val2": "16.00",
          "chgp": "110.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.89",
          "val2": "3.72",
          "chgp": "85.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.53",
          "val2": "0.35",
          "chgp": "51.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.07",
          "val2": "2.50",
          "chgp": "102.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.51%",
          "val2": "23.25%",
          "chgp": "-2.74%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Sep'25
Change(%)
Net Sales
19.54
14.06
38.98%
Operating Profit (PBDIT) excl Other Income
3.56
3.29
8.21%
Interest
0.27
0.26
3.85%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.69
2.33
15.45%
Operating Profit Margin (Excl OI)
18.22%
23.40%
-5.18%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Mar 2026 is 38.98% vs 29.59% in Sep 2025

Direction Arrows
Standalone Net Profit

Growth in half year ended Mar 2026 is 15.45% vs 35.47% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
33.60
16.00
110.00%
Operating Profit (PBDIT) excl Other Income
6.89
3.72
85.22%
Interest
0.53
0.35
51.43%
Exceptional Items
0.00
0.00
Standalone Net Profit
5.07
2.50
102.80%
Operating Profit Margin (Excl OI)
20.51%
23.25%
-2.74%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 110.00% vs 219.36% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 102.80% vs 204.88% in Mar 2025

stock-summaryCompany CV
About Accretion Nutraveda Ltd stock-summary
stock-summary
Accretion Nutraveda Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Accretion Nutraveda Limited was initially incorporated as a Private Limited Company on March 16, 2021 and has subsequently, converted the status into a Public Limited Company vide Certificate of Incorporation issued by the Registrar of Companies, Central Processing Centre w.e.f. May 2, 2025.
Company Coordinates stock-summary
Icon
No Company Details Available